ADDRESSING ADHD SYMPTOMS WITH NEUROFEEDBACK: A COMPREHENSIVE REVIEW

Abstract

attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by impairing levels of inattention, disorganization, and hyperactivity-impulsivity. This disorder, which affects individuals across the lifespan, results in significant impairments in social, academic, and occupational functioning. The prevalence of ADHD has been on the rise, with a notable increase in US children from 2009–2011 to 2015–2017. In light of the available treatments for ADHD, both pharmacological and non-pharmacological, this paper focuses on neurofeedback as a non-invasive intervention strategy. Neurofeedback, also known as Electroencephalographic (EEG) biofeedback or Neurotherapy, is a non-pharmacological treatment that has gained attention for its potential in addressing attention deficits and improving academic performance. It operates through a Bran-Computer Interface (BCI) and utilizes NF software and hardware, including an EEG cup and peripheral devices. Neurofeedback can be used as a standalone treatment or in combination with medication, as advised by physicians.

The purpose of this paper is to explore the effectiveness of neurofeedback as a treatment for ADHD. The literature review will examine studies that investigate the impact of neurofeedback on ADHD symptoms and associated impairments. Additionally, it will delve into the mechanisms underlying neurofeedback and its potential neuroplastic effects on the brain.